Jan 26, 2012
PDF Notice to issue the 1st and 2nd convertible bonds with stock option rights and the 8th stock options through placement to the third-party and convene the Extraordinary Shareholders Meeting on March 19th,2012
Jan 11, 2012
PDF Substance Patent of Nucleic Acid Delivery Technology was allowed in Japan
Dec 12, 2011
PDF Substance Patent of Therapeutic Proteins Delivery was allowed in the United States
Oct 11, 2011
PDF New Research Collaboration Agreement between NanoCarrier and LFB Biotechnologies on Recombinant Human Coagulation Factor VIIa for Hemophilia
Sep 26, 2011
PDF License and co-development agreement on Epirubicin Micelle (NC-6300) with Kowa Company, Ltd. as well as capital increase by allotting shares to Kowa
Sep 20, 2011
PDF Substance Patent of Therapeutic Proteins Delivery was approved in Japan
Sep 02, 2011
PDF A Substance Patent of "pH-Sensitive Micelle" was allowed in China
Aug 24, 2011
PDF Contribution to an Official Committee Activity regarding the Extension of a Patent Duration
Aug 22, 2011
PDF Substance patent of the Paclitaxel-micelle (NK105) was allowed in South Korea
Aug 09, 2011
PDF Research Collaboration Agreement with Kyoto University
Aug 09, 2011
PDF Substance patent of a Gene Carrier was allowed in Canada
Jul 20, 2011
PDF Commencement of Clinical Phase II of Nanoplatin® (NC-6004)
Jul 15, 2011
PDF Option Agreement between NanoCarrier and LFB Biotechnologies
Jun 10, 2011
PDF Substance patent applications of "pH-Sensitive Micelle" and "Sensor Linked Micelle" are allowed(going to be registered)
Jun 03, 2011
PDF Substance patent of the Paclitaxel-micelle (NK105) was allowed in Canada
Jun 01, 2011
PDF Substance patent of the Paclitaxel-micelle (NK105) was allowed in Japan
May 12, 2011
PDF Financial Results for the year ended March 31, 2011 〔Japan GAAP〕 (non-consolidated)
May 10, 2011
PDF Substance patent of DACH-platin Analogue Micelle was allowed in USA
Mar 28, 2011
PDF Substance patent of Nucleic Acid Delivery Technology was registered in Japan
Mar 24, 2011
PDF Extension of Option Agreement between NanoCarrier and LFB Biotechnologies
Mar 24, 2011
PDF Termination Agreement of License and Supply Agreement for DACH-platin Analogue Micelle
Mar 16, 2011
PDF Substance patent of Nucleic Acid Delivery Technology was registered in Japan
Feb 16, 2011
PDF Research article on Nanoplatin® (NC-6004) was published
Jan 13, 2011
PDF Process patent and formulation patent of DACH-platin Analogue Micelle were allowed
Jan 11, 2011
PDF Formulation-related patent of drug-incorporated micelle was allowed in the main Asian countries
Jan 06, 2011
PDF Notice on Publication of Research Article by Professor Kataoka, Scientific Advisor of NanoCarrier
Dec 21, 2010
PDF Notice on the collaboration with National Cancer Center
Dec 17, 2010
PDF Notice of issuance of new shares in rights offering
Dec 10, 2010
PDF Substance patent of DACH-platin Analogue Micelle was allowed in the main countries in Asia-Oceania area
Nov 19, 2010
PDF Substance patent applications of "pH-Sensitive Micelle" and "Sensor Linked Micelle" were allowed (going to be registered).
Oct 20, 2010
PDF NanoCarrier and LFB Biotechnologies Collaborate on Recombinant Human Coagulation Factor VIIa for Hemophilia
Oct 13, 2010
PDF Notice of issuance of new shares in rights offering (Corrected version)
Detail of Correction due to translation error
Sep 30, 2010
PDF Notice of issuance of new shares in rights offering
Sep 28, 2010
PDF 「Development of Systemic Drug Delivery Technology for Protein and siRNA」
9th France-Japan DDS Symposium
”Recent Trends in Gene and Drug Delivery"
September 26-29,2010
Ichiro Nakatomi
Sep 21, 2010
PDF Termination of License and Supply Agreement for DACH-platin Analogue Micelle
Sep 03, 2010
PDF Status Report
Jun 07, 2010
PDF [NOTICE] Completion of Payment for New Share Issuance Through Third-Party Allocation
May 19, 2010
PDF [NOTICE] Allocation of shares to third party
May 14, 2010
PDF Financial Results for the year ended March 31, 2010 (non-consolidated)
Feb 01, 2010
PDF Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2010 (Non-consolidated)